All Stories

  1. Reduction in Pigment Epithelial Detachment Thickness with Faricimab vs Aflibercept 2 mg During Head-to-Head Dosing in TENAYA/LUCERNE
  2. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES
  3. LONGITUDINAL OUTCOMES STUDY OF SUTURELESS SCLERAL-FIXATED INTRAOCULAR LENSES
  4. Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
  5. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography
  6. Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
  7. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
  8. METformin FOR the MINimization of Geographic Atrophy Progression (METforMIN) – A Randomized Trial
  9. Federated Learning in Diagnosing Age-Related Macular Degeneration
  10. Optimizing the OCTA layer fusion option for deep learning classification of diabetic retinopathy
  11. Federated Learning for Diagnosis of Age-related Macular Degeneration
  12. COMPARATIVE ANALYSIS OF OCT AND OCT ANGIOGRAPHY CHARACTERISTICS IN EARLY DIABETIC RETINOPATHY
  13. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  14. Normalized Blood Flow Index in Optical Coherence Tomography Angiography Provides a Sensitive Biomarker of Early Diabetic Retinopathy
  15. Multi-fusion strategies for deep learning artery and vein segmentation in OCT angiography
  16. Comparison of AI and dilated eye exams for the detection of diabetic retinopathy
  17. Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
  18. Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
  19. Rhegmatogenous retinal detachment surgery: A review
  20. Automated Region of Interest Selection Improves Deep Learning-Based Segmentation of Hyper-Reflective Foci in Optical Coherence Tomography Images
  21. AVA-Net: an open-source deep learning network for arterial-venous area segmentation in OCT angiography
  22. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  23. MF-AV-Net: an open-source deep learning network with multimodal fusion options for artery-vein segmentation in OCT angiography
  24. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY
  25. From Data to Deployment
  26. Comparative feature analysis in OCT and OCT angiography of diabetic retinopathy
  27. Quantitative features for objective assessment of OCT angiography
  28. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
  29. Imaging and artificial intelligence for progression of age-related macular degeneration
  30. Bilateral Macular Schisis in a Woman
  31. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
  32. Closure of Full-Thickness Macular Holes Associated with Macular Edema with Medical Therapy
  33. Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity
  34. Deep learning artery-vein classification in OCT angiography
  35. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography
  36. Sickle Cell Retinopathy
  37. AV-Net: deep learning for fully automated artery-vein classification in optical coherence tomography angiography
  38. Reply
  39. Transfer Learning for Automated OCTA Detection of Diabetic Retinopathy
  40. VASCULAR COMPLEXITY ANALYSIS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC RETINOPATHY
  41. Quantitative analysis of vascular complexity in OCTA of diabetic retinopathy
  42. Deep learning for objective OCTA detection of diabetic retinopathy
  43. Retinal Vein Occlusions Preferred Practice Pattern®
  44. Idiopathic Macular Hole Preferred Practice Pattern®
  45. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®
  46. Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern®
  47. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
  48. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY
  49. Diabetic Retinopathy Preferred Practice Pattern®
  50. Age-Related Macular Degeneration Preferred Practice Pattern®
  51. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern®
  52. “Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis
  53. AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY
  54. Relating retinal blood flow and vessel morphology in sickle cell retinopathy
  55. Contrast sensitivity is associated with outer‐retina thickness in early‐stage diabetic retinopathy
  56. Hypotony and the Argus II retinal prosthesis: causes, prevention and management
  57. Simulating vascular leakage on optical coherence tomography angiography using an overlay technique with corresponding thickness maps
  58. Supervised Machine Learning Based Multi-Task Artificial Intelligence Classification of Retinopathies
  59. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies
  60. Bilateral Blurry Vision in a Human Leukocyte Antigen B27–Positive Man
  61. Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy
  62. Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy
  63. Differential Artery–Vein Analysis Improves the Performance of OCTA Staging of Sickle Cell Retinopathy
  64. OCT feature analysis guided artery-vein differentiation in OCTA
  65. Quantitative artery-vein analysis in optical coherence tomography angiography of diabetic retinopathy
  66. Management of severe retinal detachment
  67. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration
  68. Diagnostic accuracy and reliability of retinal pathology using the Forus 3nethra fundus camera compared to ultra wide-field imaging
  69. Progression of Geographic Atrophy in Age-related Macular Degeneration
  70. Macular Vitelliform-Like Lesion in an Eye With Chronic Retinal Detachment
  71. Color Fundus Image Guided Artery-Vein Differentiation in Optical Coherence Tomography Angiography
  72. Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
  73. COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY
  74. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study
  75. Cyst Masquerading as Inadvertent Bleb After a Scleral-Fixated Intraocular Lens in Marfan Syndrome: A Case Report
  76. Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes
  77. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
  78. Combining ODR and Blood Vessel Tracking for Artery–Vein Classification and Analysis in Color Fundus Images
  79. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications
  80. Automated classification and quantitative analysis of arterial and venous vessels in fundus images
  81. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
  82. Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy
  83. Cholesterol Crystals Secondary to Coats-Like Response With Retinitis Pigmentosa
  84. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion
  85. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
  86. YAG Laser Vitreolysis—Is It as Clear as It Seems?
  87. Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography
  88. Acute Vision Loss and Bilateral Macular Lesions
  89. Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy
  90. Profound Macular Ischemia on Optical Coherence Tomography Angiography in Severe Diabetic Retinopathy
  91. Pupillary responses in non-proliferative diabetic retinopathy
  92. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography
  93. Headaches and Foggy Vision in a 21-Year-Old Woman
  94. The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction
  95. Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography
  96. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
  97. Worldwide Argus II implantation: recommendations to optimize patient outcomes
  98. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  99. Chronic Visual Disturbance in a Young Healthy Man
  100. Painful Red Eye in a Woman in Her 70s
  101. Cross-Sectional analysis of neurocognitive function, retinopathy, and retinal thinning by Spectral-Domain optical coherence tomography in sickle cell patients
  102. Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy
  103. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  104. Outcome of Treatment of Uveitic Macular Edema
  105. Blurred Vision in a Woman Who Had Sphenoid Wing Meningioma
  106. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment
  107. New Pigmented Lesion Over a Site of Tumor Treatment
  108. Inner and Outer Retinal Thickness Mapping of Nonproliferative Diabetic Retinopathy by Spectral-Domain Optical Coherence Tomography
  109. Subconjunctival Hemorrhages and Retinal Vascular Abnormalities
  110. Conjunctival microvascular haemodynamics in sickle cell retinopathy
  111. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
  112. Sudden-Onset Paracentral Vision Loss
  113. Wavefront Error Correction with Adaptive Optics in Diabetic Retinopathy
  114. Optical Coherence Tomography Retinal Thickness and Volume Measurements in X-Linked Retinoschisis
  115. Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
  116. Cotton-Wool Spots and Retinal Hemorrhages
  117. Neural Constraints on Visual Acuity in Proliferative Diabetic Retinopathy
  118. A Method for En Face OCT Imaging of Subretinal Fluid in Age-Related Macular Degeneration
  119. INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION IN OCULAR HISTOPLASMOSIS
  120. Smudge in My Vision
  121. Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease
  122. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
  123. Peripapillary Retinal Nerve Fiber Layer Thickness in Sickle-Cell Hemoglobinopathies Using Spectral-Domain Optical Coherence Tomography
  124. MULTIFOCAL RETINAL ASTROCYTIC HAMARTOMAS
  125. Age-Related Macular Degeneration
  126. Ophthalmic manifestations of sickle cell disease
  127. EN FACE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OUTER RETINAL ANALYSIS AND RELATION TO VISUAL ACUITY
  128. Object Frequency Characteristics of Visual Acuity
  129. Reply
  130. Feasibility of a Method for En Face Imaging of Photoreceptor Cell Integrity
  131. Structural and Functional Correlation in Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography and Scanning Laser Ophthalmoscope Microperimetry
  132. Sustained-Release Intravitreal Liquid Drug Delivery Using Triamcinolone Acetonide for Cystoid Macular Edema in Retinal Vein Occlusion
  133. Central Macular Splaying and Outer Retinal Thinning in Asymptomatic Sickle Cell Patients by Spectral-Domain Optical Coherence Tomography
  134. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  135. A COMPARISON OF HYPOXIA-INDUCIBLE FACTOR-α IN SURGICALLY EXCISED NEOVASCULAR MEMBRANES OF PATIENTS WITH DIABETES COMPARED WITH IDIOPATHIC EPIRETINAL MEMBRANES IN NONDIABETIC PATIENTS
  136. Chronic Coccidioidomycosis Endophthalmitis without Concomitant Systemic Involvement: A Clinicopathological Case Report
  137. REGRESSION OF CHOROIDAL NEOVASCULARIZATION AFTER VITRECTOMY FOR POSTINJECTION ENDOPHTHALMITIS
  138. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  139. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 2: 810-Nanometer Laser to Eyes With Drusen: Bilaterally Eligible Patients
  140. Reply
  141. Update on Laser Treatment of Diabetic Macular Edema
  142. Pharmacotherapy of age-related macular degeneration
  143. A Pilot Study of Fourier-Domain Optical Coherence Tomography of Retinal Dystrophy Patients
  144. Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy
  145. Primary transpupillary thermotherapy for small choroidal melanomas
  146. Presumed ocular tuberculosis presenting as a branch retinal vein occlusion in the absence of retinal vasculitis or uveitis
  147. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF
  148. Xanthogranuloma of the Iris Simulating Melanoma in an Adult
  149. New treatments for neovascular acute macular degeneration
  150. Pharmacotherapy for neovascular age-related macular degeneration: clinical trials and the art of medicine
  151. MACULAR DEGENERATION: THE LATEST IN CURRENT MEDICAL MANAGEMENT
  152. GROUP B STREPTOCOCCAL ENDOGENOUS ENDOPHTHALMITIS IN A NEONATE
  153. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible Patients
  154. Photodynamic Therapy for Choroidal Neovascularisation Secondary to Inflammatory Chorioretinal Disease
  155. ONE-YEAR RESULTS OF A PILOT STUDY USING ORAL 13-CIS RETINOIC ACID AS A TREATMENT FOR SUBFOVEAL PREDOMINANTLY OCCULT CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  156. Hastening Choroidal Neovascularization: The Irony of Prophylactic Laser in Unilateral Eyes With High-Risk Drusen
  157. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells
  158. Neuropilin-1 Expression by Endothelial Cells and Retinal Pigment Epithelial Cells in Choroidal Neovascular Membranes
  159. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE
  160. SCOTOMAS OF AGE-RELATED MACULAR DEGENERATION DETECTED AND CHARACTERIZED BY MEANS OF A NOVEL THREE-DIMENSIONAL COMPUTER-AUTOMATED VISUAL FIELD TEST
  161. Atypical Presentation of Multiple Evanescent White Dot Syndrome Involving Granular Lesions of Varying Size
  162. Outcomes of 140 Consecutive Cases of 25-Gauge Transconjunctival Surgery for Posterior Segment Disease
  163. Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome
  164. Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
  165. Posterior uveal effusion syndrome after trabeculectomy in an eye with ocular venous congestion
  166. Diagnostic and Therapeutic Challenges
  167. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia
  168. Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: A prospective randomized trial
  169. Indocyanine green angiography in chorioretinal diseases: indications and interpretation
  170. Diabetic macular edema: review and update
  171. Macular disease
  172. Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials
  173. Update on pseudophakic cystoid macular edema treatment options
  174. Uveal metastasis 43 years after resection of bronchogenic carcinoid
  175. COMPARISON OF NONMYDRIATIC DIGITIZED VIDEO FUNDUS IMAGES WITH STANDARD 35-MM SLIDES TO SCREEN FOR AND IDENTIFY SPECIFIC LESIONS OF AGE-RELATED MACULAR DEGENERATION
  176. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
  177. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss
  178. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
  179. Vitrectomy and membrane dissection surger: Author reply
  180. Exudative retinal detachment in relapsing polychondritis
  181. PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANE SECONDARY TO CAT SCRATCH NEURORETINITIS
  182. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic th...
  183. Radioactive plaque therapy for metastatic choroidal carcinoma
  184. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report numb...
  185. Vitreoretinal surgery through multifocal intraocular lenses compared with monofocal intraocular lenses in fluid-filled and air-filled rabbit eyes
  186. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy
  187. Retina Vitreous-Macula
  188. Iatrogenic Choroidal Neovascularization
  189. Multiple evanescent white dot syndrome in older patients
  190. PARANEOPLASTIC RETINAL SYNDROMES
  191. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis
  192. Macular Hole Surgery Using Thrombin-Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane
  193. MACULAR HOLE SURGERY USING THROMBIN-ACTIVATED FIBRINOGEN AND SELECTIVE REMOVAL OF THE INTERNAL LIMITING MEMBRANE
  194. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6
  195. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9
  196. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10
  197. SYMPTOMATIC AGE-RELATED MACULAR DEGENERATION IN ASIAN PATIENTS
  198. Hydrogel Exoplant Fragmentation 10 Years After Scleral Buckling Surgery
  199. Indocyanine Green Angiography-guided Photocoagulation of Choroidal Neovascularization Associated With Retinal Pigment Epithelial Detachment
  200. Ultrapower surgical drill system evaluation
  201. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study
  202. Retained Lens Material Masquerading as a Growing, Pigmented Iris Tumor
  203. Ciliary Body Endophotocoagulation during Pars Plana Vitrectomy in Eyes with Vitreoretinal Disorders and Concomitant Uncontrolled Glaucoma
  204. Recent developments in indocyanine green angiography
  205. Postoperative Hypopyon After Intravitreal Bovine Thrombin for Macular Hole Surgery
  206. Anaphylactic Shock Following Indocyanine Green Angiography
  207. CLINICOPATHOLOGIC FEATURES OF INDOCYANINE GREEN ANGIOGRAPHY-IMAGED, SURGICALLY EXCISED CHOROIDAL NEOVASCULAR MEMBRANES
  208. RETINOBLASTOMA RECURRENCE AFTER IODINE 125 PLAQUE APPLICATION
  209. Submacular Hemorrhage Removal
  210. Selective Use of Indocyanine Green Angiography for Occult Choroidal Neovascularization
  211. Correspondence
  212. Indocyanine Green Angiography
  213. Subretinal Hemorrhage
  214. The Role of Gravity in Gentamicin-Induced Toxic Effects in a Rabbit Model
  215. Candidal Retinitis in a Gynecologic Patient
  216. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery-Reply
  217. Improved Visual Results after Surgical Repair of Cytomegalovirus-related Retinal Detachments
  218. ADENOMA OF THE NONPIGMENTED CILIARY EPITHELIUM
  219. Aminoglycoside Toxicity in the Treatment of Endophthalmitis
  220. Foveomacular Dystrophy
  221. A New Syndrome of Myelinated Nerve Fibers, Vitreoretinopathy, and Skeletal Malformations
  222. Laser Treatment of Choroidal Neovascularization in Patients With Angioid Streaks
  223. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery
  224. Intraocular Tissue Plasminogen Activator Concentrations after Subconjunctival Delivery
  225. VISUAL ABNORMALITIES ASSOCIATED WITH HIGH-ENERGY MICROWAVE EXPOSURE
  226. Late-onset Sterile Endophthalmitis After Molteno Tube Implantation
  227. Successful Treatment of Gram-negative Endophthalmitis With Intravitreous Ceftazidime
  228. ATYPICAL PARAFOVEAL TELANGIECTASIS WITH SUBSEQUENT ANTERIOR AND POSTERIOR SEGMENT NEOVASCULARIZATION
  229. Macular Hole Formation Following Laser Photocoagulation of Choroidal Neovascular Membranes in a Patient With Presumed Ocular Histoplasmosis
  230. What to tell the patient with optic neuritis about multiple sclerosis
  231. Intraocular Penetration of Topical Tissue Plasminogen Activator
  232. Anterior Granulomatous Uveitis in Patients with Multiple Sclerosis
  233. Brown-McLean Syndrome
  234. Penetrating Ocular Injury From Contaminated Eating Utensils
  235. A Retinal Pigment Epithelium Tear in a Patient With Angioid Streaks
  236. Assessment of Intraocular Pressure in Vitrectomized Gas-Containing Eyes
  237. Retinal Pigment Epithelium Tear in a Diabetic Patient With Exudative Retinal Detachment Following Panretinal Photocoagulation and Filtration Surgery
  238. Idiopathic Sclerochoroidal Calcification
  239. Comparison of the Challenger Digital Applanation Tonometer and the Goldmann Applanation Tonometer
  240. Ultraviolet light absorbing pseudophakos